MiNK Therapeutics, Inc. (NASDAQ:INKT) Given Average Recommendation of “Hold” by Brokerages

MiNK Therapeutics, Inc. (NASDAQ: INKT - Get Free Report) has received a consensus rating of "Hold" from the five research firms that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have given a hold rating, one has assigned a buy rating and one has given